List of Corbus Pharmaceuticals patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10369131 Ultrapure tetrahydrocannabinol-11-oic acids	Patent 10369131 was granted and assigned to Corbus Pharmaceuticals on August, 2019 by the United States Patent and Trademark Office.	Corbus Pharmaceuticals	Corbus Pharmaceuticals	United States Patent and Trademark Office	10369131	August 6, 2019
‌ US Patent 10154986 Ultrapure tetrahydrocannabinol-11-oic acids	Patent 10154986 was granted and assigned to Corbus Pharmaceuticals on December, 2018 by the United States Patent and Trademark Office.	Corbus Pharmaceuticals	Corbus Pharmaceuticals	United States Patent and Trademark Office	10154986	December 18, 2018
‌ US Patent 10085964 Ultrapure tetrahydrocannabinol-11-oic acids	Patent 10085964 was granted and assigned to Corbus Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.	Corbus Pharmaceuticals	Corbus Pharmaceuticals	United States Patent and Trademark Office	10085964	October 2, 2018
‌ US Patent 11052066 Ultrapure tetrahydrocannabinol-11-oic acids	Patent 11052066 was granted and assigned to Corbus Pharmaceuticals on July, 2021 by the United States Patent and Trademark Office.	Corbus Pharmaceuticals	Corbus Pharmaceuticals	United States Patent and Trademark Office	11052066	July 6, 2021
‌ US Patent 9801849 Ultrapure tetrahydrocannabinol-11-oic acids	Patent 9801849 was granted and assigned to Corbus Pharmaceuticals on October, 2017 by the United States Patent and Trademark Office.	Corbus Pharmaceuticals	Corbus Pharmaceuticals	United States Patent and Trademark Office	9801849	October 31, 2017
‌ US Patent 9820964 Ultrapure tetrahydrocannabinol-11-oic acids	Patent 9820964 was granted and assigned to Corbus Pharmaceuticals on November, 2017 by the United States Patent and Trademark Office.	Corbus Pharmaceuticals	Corbus Pharmaceuticals	United States Patent and Trademark Office	9820964	November 21, 2017